Neolife Medical Center is a private healthcare center headquartered in Istanbul, Türkiye, founded in 2010, specializing in oncology, nuclear medicine, radiation oncology, and targeted radionuclide therapy.
With over 14 years of experience in cancer diagnosis and treatment, the center combines advanced diagnostic imaging, radionuclide therapy, and radiation oncology with a multidisciplinary team to deliver individualized, patient-centered care for domestic and international patients.
Neolife welcomes patients from across Europe, the Middle East, Asia, and Africa, offering diagnostic procedures, personalized treatment plans, and international patient assistance.
Accreditation and International Expansion
Neolife holds Joint Commission International (JCI) accreditation (2013, 2016) and ISO 9001 certification (2012, updated 2015). Following the growth of its Istanbul site, the center has expanded into Romania, with locations in Bucharest (2014), Iasi (2016), Brasov (2018), Enayati Medical City (2021), Valcea (2023), and Braila (2023).
Scale and Patient Reach
Over 14 years, Neolife has treated more than 90,000 patients and conducted over 78,000 medical scans, serving patients from more than 80 countries, including 10,000 international patients. The center's multidisciplinary team includes 12 doctors working across 10 departments, treating around 10,000 patients a year.
Medical Oncology
Neolife provides medical oncology services for patients with breast, lung, prostate, colorectal, pancreatic, liver, head and neck, gynecological, and other cancers, combining established systemic therapies with selected supportive and complementary approaches based on diagnosis, disease stage, previous treatments, and clinical condition.
- chemotherapy
- immunotherapy
- targeted therapy
- hormonal therapy, for certain hormone-sensitive breast and prostate cancers
- oncologic hyperthermia, as a complementary approach in selected cases
- oxygen therapy, as part of individualized supportive care
- supportive oncology care
- multidisciplinary tumor board evaluations
Nuclear Medicine and Targeted Radionuclide Therapies
Nuclear medicine and theranostics, combining molecular imaging with targeted radionuclide treatments, are among Neolife's areas of specialization:
- lutetium-177 PSMA therapy (Lu-177 PSMA): a radioligand therapy for eligible patients with advanced, including metastatic castration-resistant, prostate cancer
- lutetium-177 DOTATATE therapy (Lu-177 DOTATATE): a peptide receptor radionuclide therapy (PRRT) for eligible patients with somatostatin receptor-positive neuroendocrine tumors
- actinium-225 PSMA therapy (Ac-225 PSMA): a targeted alpha therapy considered for selected patients with advanced prostate cancer when conventional treatments have provided limited benefit
- radioactive iodine therapy (I-131), for selected thyroid conditions including differentiated thyroid cancer and certain forms of hyperthyroidism
- yttrium-90 (Y-90) radioembolization, for selected patients with liver tumors
Advanced PET/CT and Molecular Imaging
Diagnostic imaging services supporting cancer detection, staging, treatment selection, and response monitoring include:
- F-18 FDG PET/CT
- Ga-68 PSMA PET/CT
- Ga-68 DOTATATE PET/CT
- FAPI PET/CT
- choline PET/CT
- brain PET imaging
- bone, thyroid, and renal scintigraphy
- SPECT/CT imaging
Radiation Oncology
Radiation oncology services use precision-based techniques, including:
- intensity-modulated radiation therapy (IMRT)
- image-guided radiation therapy (IGRT)
- volumetric modulated arc therapy (VMAT)
- stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS)
- 3D brachytherapy
Radiology and Diagnostic Imaging
- 3 Tesla and whole-body MRI, including multiparametric prostate and liver MRI
- computed tomography (CT) and coronary CT angiography
- digital mammography and tomosynthesis
- breast ultrasound and Doppler ultrasonography
Preventive Healthcare and Screening
Beyond cancer treatment, Neolife offers personalized check-up packages, early cancer detection programs, cardiovascular assessments, laboratory investigations, and screening programs for women and men. Additional services include telemedicine, tele-reporting, online consultations, and training for healthcare professionals in radiotherapy planning, pathology, genetics, and radiation protection.
Multidisciplinary Care Pathway
Neolife follows a structured, personalized oncology care pathway integrating molecular tumor boards, oncological surgery, radiology, interventional radiology, medical oncology, radiation oncology, and theranostics. Medical oncologists, radiation oncologists, nuclear medicine specialists, radiologists, and surgeons collaborate on complex, advanced, recurrent, and metastatic cancer cases.
Patient Support
As part of its social responsibility initiatives, Neolife provides psychological support, drama and art therapy, and patient support groups.
International Patient Services
For international patients, Neolife provides:
- evaluation of medical records and diagnostic reports
- specialist consultations and second medical opinions
- individualized treatment plans and cost estimates
- appointment and treatment scheduling
- multilingual interpretation and 24/7 assistance
- accommodation and local transportation arrangements
- airport pick-up and farewell services
- coordination of diagnostic procedures and treatment sessions, and post-treatment follow-up
Individual treatment program and cost estimate
Average answering time – 5 minutes
